CONMED Corporation (CNMD) Sets 1-Year High on May, 16

May 16, 2018 - By Pearl Odom

CONMED Corporation (NASDAQ:CNMD) Corporate Logo

Big Money Sentiment decreased to 1.3 in 2017 Q4. It has change of 0.04, from 2017Q3’s 1.34. The ratio fall due to CONMED Corporation positioning: 7 sold and 46 reduced. 25 funds took stakes and 44 increased stakes. Investors holded 27.14 million in 2017Q3 but now own 26.91 million shares or 0.87% less.
Fisher Asset Mngmt Ltd Com holds 615,878 shs. Pub Employees Retirement Of Ohio holds 1,852 shs or 0% of its capital. Bnp Paribas Arbitrage Sa invested in 0% or 14,075 shs. 10,700 were accumulated by Louisiana State Employees Retirement System. 164,547 are held by Krensavage Asset Mngmt Lc. Metropolitan Life Company Ny invested in 8,586 shs. Capital Investors stated it has 643,000 shs or 0.01% of all its holdings. Victory Mgmt Incorporated invested in 2.23M shs or 0.24% of the stock. 72,534 were accumulated by Deutsche Bankshares Ag. Renaissance Technology Limited Com reported 19,000 shs or 0% of all its holdings. Price T Rowe Associates Md invested 0% in CONMED Corporation (NASDAQ:CNMD). Hudson Bay Mngmt Lp reported 0.06% in CONMED Corporation (NASDAQ:CNMD). Westwood Gp Inc holds 0.14% or 368,745 shs. Champlain Invest Ptnrs Lc holds 1.48M shs or 0.85% of its capital. Texas Permanent School Fund holds 0.01% or 16,806 shs in its capital.

CONMED Corporation had 10 insider sales and 1 buy since January 3, 2018. This’s net activity of $4.11 million. Farkas Charles bought 158 shs worth $7,996. Folkert Nathan also sold $286,497 worth of CONMED Corporation (NASDAQ:CNMD) shs. On Monday, May 7 GOLDEN JO ANN also sold $201,690 worth of CONMED Corporation (NASDAQ:CNMD). On Monday, February 12 POMILIO LUKE A had sold 1,962 shs worth $118,211. JONAS DANIEL had sold 2,000 shs worth $131,160.

The company CONMED Corporation (NASDAQ:CNMD) touched 52 week high with $72.33 PT or 5.00 % above today’s $68.89 price per share. It was published on May, 16 according to CONMED Corporation (NASDAQ:CNMD) has $1.93 billion market cap. At our $72.33 PT, the company worth will be $96.60M more.

CNMD is touching $68.89 during the last trading session, after increased 0.98%.Currently CONMED Corporation is uptrending after 46.44% change in last May 16, 2017. CNMD has 78,152 shares volume. The stock outperformed the S&P 500 by 34.89%.

CONMED Corporation (NASDAQ:CNMD)’s earnings report is anticipated on July, 25., according to Zacks. Analysts have anticipation on stock’s earnings per share of $0.45. That’s up 9.76 % from last year’s $0.41 earnings per share. This could be $12.62 million profit for CNMD assuming the current $0.45 earnings per share will become reality. -15.09 % negative EPS growth is what Wall Street’s sees after $0.53 reported EPS previous quarter.

CONMED Corporation (NASDAQ:CNMD) Ratings Coverage

In total 2 analysts cover Conmed Corp (NASDAQ:CNMD). “Buy” rating has 1, “Sell” are 0, while 1 are “Hold”. 50% are bullish. With $7300 highest and $54.0 lowest PT Conmed Corp has $63.50 average PT or -7.82% below the current ($68.89) price. 4 are the (NASDAQ:CNMD)’s analyst reports since November 17, 2017 according to StockzIntelligence Inc. On Friday, November 17 Needham maintained CONMED Corporation (NASDAQ:CNMD) with “Buy” rating. On Thursday, February 1 the stock of CONMED Corporation (NASDAQ:CNMD) earned “Buy” rating by Needham. On Thursday, April 26 the rating was maintained by Needham with “Buy”. On Thursday, February 1 the stock has “Hold” rating by Piper Jaffray.

Another two news for CONMED Corporation (NASDAQ:CNMD) were briefly released by: on May 09, 2018 with title “Benzinga’s Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway”. The other‘s article was titled “Market Trends Toward New Normal in Cohen & Steers, Achaogen, Ares Commercial Real Estate, CONMED, Marcus …” and released on May 02, 2018.

CONMED Corporation, a medical technology company, develops, makes, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.The firm is valued at $1.93 billion. The firm offers sports medicine products, such as powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bio absorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; and sports biologics and tissues.The P/E ratio is 34.97. It also provides electrosurgical generators, hand pieces, smoke management systems, and accessories for surgical needs; and endomechanical instrumentation products that offer various instruments comprising trocars, suction irrigation devices, graspers, scissors, and dissectors used in the minimally invasive laparoscopic and gynecological surgery, as well as an uterine manipulator for use in the laparoscopic hysterectomies and other gynecologic laparoscopic procedures.

CONMED Corporation (NASDAQ:CNMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: